Dar Zavain 4
4 · RECURSION PHARMACEUTICALS, INC. · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2025-04-01+2,745→ 110,877 total
Footnotes (1)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.